(Q37842680)

24 August 2017

1 reference

title

Shining D' light on chronic kidney disease: mechanisms that may underpin the cardiovascular benefit of vitamin D. (English)

1 reference

chronic renal insufficiency

24 August 2017

0 references

0 references

1 reference

1 reference

David W Johnson

2

0 references

author name string

William G Petchey

series ordinal

1

1 reference

PubMed ID

21323790

24 August 2017

Nicole M Isbel

series ordinal

3

1 reference

24 August 2017

1 May 2011

1 reference

24 August 2017

1 reference

24 August 2017

16

1 reference

24 August 2017

4

1 reference

24 August 2017

351-367

1 reference

Effect of aggressive risk factor modification on cardiac events and myocardial ischaemia in patients with chronic kidney disease.

24 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

Does renal failure cause an atherosclerotic milieu in patients with end-stage renal disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

Relationship between serum 1,25-dihydroxyvitamin D and mortality in patients with pre-dialysis chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

Chronic kidney disease, hypovitaminosis D, and mortality in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

25-hydroxyvitamin D levels and the risk of mortality in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

Low vitamin d levels predict stroke in patients referred to coronary angiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

Vitamin D deficiency and risk of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

Relationship of 25-hydroxyvitamin D with all-cause and cardiovascular disease mortality in older community-dwelling adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

25-hydroxyvitamin D levels, race, and the progression of kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

Association of oral calcitriol with improved survival in nondialyzed CKD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

Higher impact of mineral metabolism on cardiovascular mortality in a European hemodialysis population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

Lower risk for cardiovascular mortality in oral 1alpha-hydroxy vitamin D3 users in a haemodialysis population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

Activated injectable vitamin D and hemodialysis survival: a historical cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

Calcium/vitamin D supplementation and cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

Expanding role for vitamin D in chronic kidney disease: importance of blood 25-OH-D levels and extra-renal 1alpha-hydroxylase in the classical and nonclassical actions of 1alpha,25-dihydroxyvitamin D(3).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

25-Hydroxyvitamin D, insulin resistance, and kidney function in the Third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

Serum 25-hydroxyvitamin D3 concentrations and carotid artery intima-media thickness among type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient - a randomised, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

Calcium-independent and 1,25(OH)2D3-dependent regulation of the renin-angiotensin system in 1alpha-hydroxylase knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

Vitamin D, the renin-angiotensin system, and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

Normal and osteoporotic human osteoblast behaviour after 1,25-dihydroxy-vitamin D(3) stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

Serum osteocalcin level is associated with glucose metabolism and atherosclerosis parameters in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

Endocrine regulation of energy metabolism by the skeleton

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

Metabolism of vitamin D3 in human osteoblasts: evidence for autocrine and paracrine activities of 1 alpha,25-dihydroxyvitamin D3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

Role of vitamin D in the pathogenesis of type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

1,25-Dihydroxyvitamin D3 evokes oscillations of intracellular calcium in a pancreatic beta-cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

Effect of calcitriol on insulin secretion in uraemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

Amelioration of hypertension and insulin resistance by 1,25-dihydroxycholecalciferol in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

Intravenous 1,25 dihydroxycholecalciferol corrects glucose intolerance in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

Effect of oral calcitriol pulse therapy on the lipid, calcium, and glucose homeostasis of hemodialysis-patients: its safety in a combination with oral calcium carbonate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

The influence of intravenous 1,25(OH)2D3 therapy on glucose metabolism in hemodialyzed patients with secondary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

Prevalence of vitamin D [25(OH)D] deficiency and effects of supplementation with ergocalciferol (vitamin D2) in stage 5 chronic kidney disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

The evolving role of inflammation in obesity and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

The pathogenesis of atherosclerosis: a perspective for the 1990s

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

Vascular calcification mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

Inhibition of the transcription factors AP-1 and NF-kappaB in CD4 T cells by peroxisome proliferator-activated receptor gamma ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

Nonclassical aspects of differential vitamin D receptor activation: implications for survival in patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

Paricalcitol inhibits renal inflammation by promoting vitamin D receptor-mediated sequestration of NF-kappaB signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

A placebo-controlled trial to evaluate immunomodulatory effects of paricalcitol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

Comparative efficacy of oral and intravenous calcitriol treatment in haemodialysis patients: effects on serum biochemistry and cytokine levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

Supplementation with Alfacalcidol increases protein intake and serum albumin concentration in patients undergoing hemodialysis with hpoalbumineamia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

Paricalcitol reduces albuminuria and inflammation in chronic kidney disease: a randomized double-blind pilot trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

Cholecalciferol supplementation in hemodialysis patients: effects on mineral metabolism, inflammation, and cardiac dimension parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

Independent association between 1,25-dihydroxyvitamin D, 25-hydroxyvitamin D and the renin-angiotensin system: The Ludwigshafen Risk and Cardiovascular Health (LURIC) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

Characterization of heart size and blood pressure in the vitamin D receptor knockout mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

Suppression of renin-angiotensin gene expression in the kidney by paricalcitol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

Physiology and pharmacology of the (pro)renin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

Combination therapy with paricalcitol and trandolapril reduces renal fibrosis in obstructive nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

Therapeutic effects of vitamin D analogs on cardiac hypertrophy in spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

Effect of intravenous calcitriol on cardiac systolic and diastolic function in patients on hemodialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

Calcitriol regresses cardiac hypertrophy and QT dispersion in secondary hyperparathyroidism on hemodialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

Effect of pharmacological suppression of secondary hyperparathyroidism on cardiovascular hemodynamics in predialysis CKD patients: A preliminary observation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

Vitamin D status of chronic kidney disease patients living in a sunny country

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

Altered vitamin D metabolism in type II diabetic mouse glomeruli may provide protection from diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

Calcimimetic R-568 or calcitriol: equally beneficial on progression of renal damage in subtotally nephrectomized rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

1,25-Dihydroxyvitamin D(3) prevents puromycin aminonucleoside-induced apoptosis of glomerular podocytes by activating the phosphatidylinositol 3-kinase/Akt-signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

Hereditary proteinuria syndromes and mechanisms of proteinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

Screening and identification of substances that regulate nephrin gene expression using engineered reporter podocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

Effects of 1,25(OH)2D3 in experimental mesangial proliferative nephritis in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

A vitamin D analog ameliorates glomerular injury on rat glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

Pathogenesis of nonimmune glomerulopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

Effect of 1,25 (OH)2 vitamin D3 on glomerulosclerosis in subtotally nephrectomized rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

Oral paricalcitol in the treatment of patients with CKD and proteinuria: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

Antiproteinuric effect of oral paricalcitol in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

Oral calcitriol for the treatment of persistent proteinuria in immunoglobulin A nephropathy: an uncontrolled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

Calcitriol ameliorates capillary deficit and fibrosis of the heart in subtotally nephrectomized rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

Elastin degradation and calcification in an abdominal aorta injury model: role of matrix metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

Calcitriol blunts the deleterious impact of advanced glycation end products on endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

Vitamin D analogs modulate the expression of plasminogen activator inhibitor-1, thrombospondin-1 and thrombomodulin in human aortic smooth muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

The potential for vitamin D receptor activation in cardiovascular research

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

Pulse wave velocity is inversely related to vertebral bone density in hemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

1,25-(OH)2-vitamin D3 suppresses the bone-related Runx2/Cbfa1 gene promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

Induction of matrix Gla protein synthesis during prolonged 1,25-dihydroxyvitamin D3 treatment of osteosarcoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

Calcification of medial elastic fibers and aortic elasticity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

Systemic cardiovascular disease in uremic rats induced by 1,25(OH)2D3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

Severe hyperparathyroidism with bone abnormalities and metastatic calcification in rats with adenine-induced uraemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

Vitamin D and vascular calcification

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

25-hydroxyvitamin D3-1alpha-hydroxylase is expressed in human vascular smooth muscle cells and is upregulated by parathyroid hormone and estrogenic compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

FGF-23: More than a regulator of renal phosphate handling?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

Hypovitaminosis D in Medical Inpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

Vitamin D levels and patient outcome in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2011.01450.X

10.1111/J.1440-1797.2011.01450.X

21 January 2018

Identifiers

DOI

1 reference

24 August 2017

1 reference

PubMed ID

21323790